Shares of Sotera Health (NASDAQ:SHC – Get Free Report) have earned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $16.08.
Several equities research analysts recently issued reports on the stock. The Goldman Sachs Group started coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 target price on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Finally, Citigroup increased their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th.
Check Out Our Latest Stock Analysis on SHC
Institutional Trading of Sotera Health
Sotera Health Trading Down 0.4 %
Shares of Sotera Health stock opened at $13.62 on Friday. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44. The business’s fifty day moving average is $14.05 and its two-hundred day moving average is $14.32. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The firm has a market cap of $3.86 billion, a PE ratio of 54.48 and a beta of 1.96.
Sotera Health (NASDAQ:SHC – Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The business had revenue of $285.47 million for the quarter, compared to analysts’ expectations of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business’s quarterly revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.18 earnings per share. Analysts anticipate that Sotera Health will post 0.61 earnings per share for the current year.
Sotera Health Company Profile
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Stories
- Five stocks we like better than Sotera Health
- Insider Trading – What You Need to Know
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- What Are Dividend Champions? How to Invest in the Champions
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Want to Profit on the Downtrend? Downtrends, Explained.
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.